Germany · Advertising framework
Advertising pharmacies and health retail on websites in Germany
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Distinguish pharmacy incentives by their actual mechanism
Historical enforcement context
The CJEU judgment of 27 February 2025 distinguishes immediate price reductions or exact payments for unspecified prescription medicines from vouchers encouraging later purchases of non-prescription medicines and other products. It permits different national treatment of these mechanisms; it does not authorise every German pharmacy bonus. Record the current German pricing rules, reimbursement route, pharmacy jurisdiction and benefit conditions before approving a promotion.
Sources: C-517/23 Apothekerkammer Nordrhein — judgment summary
Channel rules
Check the complete consumer-facing message
Regulator guidance
The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.
Sources: EU Unfair Commercial Practices Directive 2005/29/EC
Review personal data separately from the advertisement
Legal requirement — paraphrased
Identify an Article 6 basis for personal-data processing and an applicable Article 9 condition for health data. Provide appropriate transparency and honour the right to object to direct marketing. Permission to deliver healthcare does not automatically authorise advertising use of patient data; electronic contact and trackers also need their own local review.
Review the whole website journey
Editorial recommendation
Review the product card, metadata, testimonials, booking page and checkout together. Archive the published version and check third-party widgets after updates.
Assess terminal access separately from the GDPR basis
Legal requirement — paraphrased
Section 25 TDDDG generally requires informed consent for storing or accessing information on a user’s terminal. Its exceptions concern transmission and what is strictly necessary for a digital service expressly requested by the user.
A GDPR processing basis does not itself remove this separate consent requirement. Review advertising tags and embedded third-party services before loading them.
Campaign workflow
Check retail incentives and medicine rules together
Editorial recommendation
Review the applicable pharmacy rules and HWG section 7 before using gifts, benefits, vouchers or price mechanics. The existence of statutory exceptions is not a general permission for a pharmacy promotion.
Sources: Heilmittelwerbegesetz (HWG)
Pharmacies & Health Retail: prepare the review
Editorial recommendation
Separate promotion of the pharmacy from advertising of each medicine or other product. Verify online-supply and delivery permissions independently of advertising eligibility. Review price promotions and inducements under both retail and medicine rules.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Separate promotion of the pharmacy from advertising of each medicine or other product.
- Verify online-supply and delivery permissions independently of advertising eligibility.
- Review price promotions and inducements under both retail and medicine rules.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Nordrhein physician rules and the CJEU pharmacy-incentive distinction are documented. Binding dental codes and other Länder remain to be mapped. The exact pharmacy pricing/reimbursement route and product-specific HWG exceptions require the actual campaign facts.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
Pharmacy promotion on websites in Germany needs separate decisions about the retailer, the advertised products and any online supply. Use this guide to keep medicine restrictions, seller permissions and promotional price mechanics in the same review.
On a website, the headline, product card, testimonial, embedded video and booking or checkout page all contribute to the message. Follow the rules below across that journey, rather than reviewing the landing-page text in isolation.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Federal product-advertising rules plus EU requirements; Länder professional and provider rules need a local check. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- EU Unfair Commercial Practices Directive 2005/29/EC
EU framework implemented through national law; sector rules and local implementation also apply.
- EU General Data Protection Regulation 2016/679
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- C-517/23 Apothekerkammer Nordrhein — judgment summary
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- TDDDG — Section 25, terminal-device privacy
Targeted review on 25 October 2026. This date does not certify the currency of other sources or resolve local and campaign-specific requirements.
- Heilmittelwerbegesetz (HWG)
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
From framework to action
Local expertise in Germany
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Germany.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.